Clal Biotechnology Industries Ltd Cash Flow Reinvestment Rate

Latest as of September 2020: 4.61x

Clal Biotechnology Industries Ltd cash flow reinvestment rate. Clal Biotechnology Industries Ltd (CBI) has a Cash Flow Reinvestment Rate of 4.61x as of September 2020, reinvesting ILA5.10 Million (capex ILA806.00K plus investments ILA-4.29 Million) from operating cash flow of ILA1.10 Million. Explore CBI operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

4.61x

(Capex + Investments) / Operating CF

Total Reinvested

ILA5.10 Million

Capex + Investments

Operating Cash Flow

ILA1.10 Million

ILA

Capital Expenditures

ILA806.00K

ILA

Cash Flow Reinvestment Rate of Clal Biotechnology Industries Ltd (2019–2019)

Cash flow reinvestment rate of Clal Biotechnology Industries Ltd from 2019 to 2019. Historical reinvestment intensity for Clal Biotechnology Industries Ltd across 1 annual periods. Explore CBI capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Clal Biotechnology Industries Ltd Cash Flow Reinvestment Rate by Year (2019–2019)

Clal Biotechnology Industries Ltd cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Clal Biotechnology Industries Ltd. For the full cash flow conversion analysis, see Clal Biotechnology Industries Ltd cash conversion from operations.

Year	Reinvestment Rate	Total Reinvested (ILA)	Operating CF	Capex	YoY Change
2019	0.89x	ILA24.14 Million	ILA27.03 Million	ILA2.83 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow